Abstract:Background: The benefit of blood cholesterol reduction for secondary prevention of ischemic stroke remains undetermined in Chinese patients. The purpose of this meta-analysis was to determine whether lipid-lowering agents including statins, fibrates, nicotinic acid, and ezetimibe reduced the risk of recurrent stroke in ischemic stroke patients in China and whether such findings could inform treatment decisions for blood lipid-lowering treatment in China. Methods: The English electronic databases PubMed, EMBASE, Cochrane Library and Chinese databases CNKI, Sino-Med, Wan Fang, and VIP were searched for studies published between January 1990 and April 2020. This meta-analysis included published data from trials that randomly assigned patients to groups treated with either blood lipid-lowering regimens or placebo. Effect comparisons were made using fixed effects model in meta-analysis and linear and spline regression were performed to identify the relative risk of stroke recurrence. The primary outcome was the reduction of total ischemic stroke events, and relative risk values were obtained using a risk prediction equation developed from the control groups of the included trials. Results: Five studies including 4,999 individuals with available data met the inclusion criteria. Relative to the control groups, the pooled estimated odds ratio (OR) for recurrent stroke among those who received lipid-lowering therapy was 0.79 (95% confidence interval [CI]: 0.63–1.00). A 50% or greater reduction in low-density lipoprotein cholesterol (LDL-C) significantly reduced the risk of ischemic stroke recurrence (OR: 0.15 [95% CI: 0.11–0.20]). The overall beneficial effect of statin therapy was confirmed to prevent ischemic stroke with an OR of 0.51 (95% CI: 0.36–0.72). Conclusions: Effective lipid-lowering therapy could decrease the blood LDL-C level, which had a protective effect against stroke recurrence. These results support the use of predicted baseline cerebrovascular disease risk equations to inform decisions regarding blood lipid-lowering treatment in ischemic stroke patients in China.

The Apllication of Statins in the Treatment of Acute Ischemic Stroke

Acute statins treatment for aneurysmal subarachnoid hemorrhage might be limited: A systematic review and meta-analysis

Prior Statin Use and Intravenous Thrombolysis in Acute Ischemic Stroke: a Meta-Analysis of Cohort Studies

Application Progress of Statins in Ischemic Stroke

Research progress of natural products for the treatment of ischemic stroke

Roles of Statins in the Prevention and Treatment of Ischemic Stroke

Use of Statins for Preventing Stroke Recurrence:A Systematic Review

Prevention of Ischemic Strokes An Evaluation of Statins

The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature

Analysis on the Application of Statins for the Treatment of Early Cerebral Infarction

Effects of Statins on the Liver: Clinical Analysis of Patients with Ischemic Stroke

Low Dose Statins Improve Prognosis of Ischemic Stroke Patients with Intravenous Thrombolysis

Statin Treatment in the Acute Phase and the Risk of Post-stroke Pneumonia: A Retrospective Cohort Study.

Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke.

Low-dose Statin Pretreatment Improves Function and Prognosis of Recurrent Ischemic Stroke Patients

The Role of Statin in Primary Prevention of Ischemic Stroke

Effect of Statin on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke

Statin treatment in stroke patient with low‐density lipoprotein cholesterol levels below 70 mg/dL

Impact of atorvastatin on infarct volume of acuteischemic stroke statinnaive

Abstract T MP93: Statin Treatment May Reduce the Risk of Post-stroke Infections

Meta-Analysis of Dyslipidemia Management for the Prevention of Ischemic Stroke Recurrence in China